11. Income Taxes

The components of income before income tax expense consist of the following:

December 31,

  ​ ​ ​

2025

  ​ ​ ​

2024

United States

$

21,669

$

24,986

Foreign

71

41

Total

$

21,740

$

25,027

The components of income tax expense consist of the following:

December 31,

2025

  ​ ​ ​

2024

Current income tax expense:

US federal

 

$

453

$

7,494

US state and local

 

1,665

 

1,824

Foreign

21

9

Total current income tax expense

2,139

 

9,327

Deferred income tax expense:

US federal

4,171

 

(3,694)

US state and local

346

 

(127)

Foreign

Total deferred income tax expense

4,517

 

(3,821)

Total income tax expense:

US federal

4,624

 

3,800

US state and local

2,011

 

1,697

Foreign

21

9

Total income tax expense

$

6,656

$

5,506

For the years ended December 31, 2025 and 2024, the effective tax rate differs from the U.S. federal statutory income tax rate as follows:

December 31,

2025

  ​ ​ ​

2024

  ​ ​ ​

Amount

Percent

Amount

Percent

US federal statutory tax rate

$

4,565

21.0

%

$

5,256

21.0

%

State and local income taxes, net of federal income tax effect (1)

1,743

8.0

 

1,428

5.7

 

Foreign tax effects:

United Kingdom

3

2

Effects of changes in tax laws or rates enacted in the current period

Effect of cross-border tax laws

Tax credits:

Research and development tax credits

(239)

(1.1)

 

(223)

(0.9)

 

Other

(33)

(0.2)

(5)

Changes in valuation allowances

(1,757)

(7.0)

Nontaxable or nondeductible items:

Excess compensation (both current and future)

557

2.6

691

2.8

Share-based payment awards

158

0.7

(906)

(3.6)

Other

323

1.5

135

0.5

Changes in unrecognized tax benefits

(502)

(2.3)

(897)

(3.6)

Other adjustments:

Expiration of capital loss carryover

1,757

7.0

Other

81

0.4

25

0.1

Effective tax rate

$

6,656

30.6

%

$

5,506

22.0

%

(1) The majority of the state tax effect relates to Minnesota and California.

The increase in the Company’s effective tax rate for the year ended December 31, 2025 compared to the prior year related to non-deductible acquisition-related costs and increased state tax expenses related to the acquisition of Arroweye. The effective tax rate for the year ended December 31, 2024 was impacted by the increased deductibility of stock-based compensation realized upon certain stock option exercises and restricted stock unit vesting.

For the year ended December 31, 2025, the effective tax rate differs from the federal statutory rate primarily due to state income taxes, which had a tax rate impact of 8.0%. Other items impacting the effective tax rate in 2025 include tax deductibility limitations on executive compensation and permanent items. For the year ended December 31, 2024, the effective tax rate differs from the federal statutory rate primarily due to state income taxes, which had a tax rate impact of 5.7%. Other items impacting the effective tax rate in 2024 include tax deductibility limitations on executive compensation, permanent items and unrecognized tax benefits due to statute of limitations.

The amount of taxes paid (net of refunds received) consist of the following:

December 31,

  ​ ​ ​

2025

  ​ ​ ​

2024

US federal

$

5,000

$

8,350

US state and local:

Minnesota

 

650

75

Other

 

733

 

849

Subtotal

1,383

 

924

Foreign:

Other

14

 

11

Subtotal

14

 

11

Total

 

$

6,397

$

9,285

The components of the deferred tax assets and liabilities are as follows:

December 31,

  ​ ​ ​

2025

2024

Deferred tax assets:

Accrued expense

$

3,250

$

3,414

Net operating loss carryforward

22,648

 

133

Stock-based compensation

2,174

 

2,400

Interest limitation

3,920

2,424

Lease liability

5,200

2,730

Research and development costs

722

2,070

Other

2,413

2,772

Total gross deferred tax assets

40,327

 

15,943

Valuation allowance

 

(15,556)

 

(872)

Net deferred tax assets

24,771

 

15,071

Deferred tax liabilities:

Plant, equipment and leasehold improvements

 

(12,489)

 

(8,552)

Intangible assets

 

(8,258)

 

(6,075)

Right-of-use assets

(5,042)

(2,511)

Prepaid expenses and other

(1,233)

(1,251)

Total gross deferred tax liabilities

 

(27,022)

 

(18,389)

Net deferred tax liabilities

$

(2,251)

$

(3,318)

The valuation allowance as of December 31, 2025, is primarily related to Arroweye’s net operating losses that are limited to taxable income generated from acquired business, and the use of state interest deductions that may generate future state net operating losses, which may not be fully recognized.

The Company has state and local operating loss carryforwards which will expire at various dates from 2033 to 2038. The Company generally expects to be able to utilize these losses prior to expiration, but applied a valuation allowance to losses that may not be fully recognized.

The Company has recorded compensation for certain covered employees in excess of $1.0 million per year. Under Internal Revenue Code (IRC) Section 162(m), the Company is prohibited from deducting the amount of tax compensation that exceeds $1.0 million per year for these employees. The covered employees are defined as the CEO, Chief Financial Officer (“CFO”), and the three next-highest-compensated officers of the Company. The Company considers the impact of the estimated IRC Section 162(m) limitations on the future deductibility of existing temporary differences.

Unrecognized Tax Benefits

Unrecognized tax benefits represent the aggregate tax effect of differences between the tax return positions and the amounts otherwise recognized in the Company’s consolidated financial statements, and are reflected in “Accrued expenses” and “Other long-term liabilities” on the Company’s consolidated balance sheets. The Company accounts for uncertain tax positions by recognizing the financial statement effects of a tax provision only when based upon the technical merits, it is “more-likely-than-not” that the tax position will be sustained upon examination.

Balance as of December 31, 2024

$

669

Increase related to current year tax position

97

Increase related to prior year tax position

22

Decrease related to prior year tax position

Decrease related to lapse of statute of limitations

(436)

Balance as of December 31, 2025

$

352

The amount of unrecognized tax benefits that, if recognized, would impact the annual effective tax rate is $0.4 million and $0.7 million for the years ended December 31, 2025 and 2024, respectively.

The Company recognizes interest and penalties with respect to unrecognized tax benefits as a component of income tax expense. The amount of accrued interest and penalties related to unrecognized tax benefits was $0.1 million for each of the years ended December 31, 2025 and 2024. The Company remains subject to U.S. federal, state and foreign examinations for years after 2020.

Historical Timeline

Fiscal YearFiled
2025Mar 5, 2026Showing above
2024Mar 4, 2025

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.